Nucor has delivered a strong long term run, yet the recent pullback in the share price puts fresh focus on whether the current valuation still lines up with the cash the business can generate. With the stock now reacting to shifting expectations around earnings and shareholder returns, the issue is whether its cash flows are enough to support where the market is pricing it today.
The stock's next move may depend on whether Nucor's current share price is justified by the intrinsic value implied by its future cash flows.
For a broader watchlist of companies where you can explore the same cash flow question that investors are asking of Nucor, start with 40 high quality undervalued stocks.
The Discounted Cash Flow (DCF) model here uses Nucor's own cash generation as the anchor. Latest twelve month free cash flow sits at about $1.83b, and the projection path assumes this builds into the $5b range over time rather than shrinking away.
That means the framework is treating Nucor as a mature producer that can keep generating meaningful cash, not a high growth story or a turnaround. Because UBS recently upgraded the stock on expectations of stronger earnings and more disciplined capital spending, the DCF view of healthier free cash flow helps explain why the model sees intrinsic value substantially above the current $239.62 share price. The Discounted Cash Flow projections put Nucor's estimated intrinsic value substantially above the current share price. Find out what Nucor could be worth using our Discounted Cash Flow (DCF) estimate.
Nucor's valuation puzzle highlights the role of Simply Wall St Narratives. These short scenarios explain which future paths for growth, profitability and earnings would need to occur for the shares to appear materially higher or lower than today. Each scenario links its number to a specific view on where Nucor's growth, margins and risks may go next, providing something concrete to track as new information becomes available.
One of the top narratives on Nucor: 20% undervalued
This Narrative is the analyst consensus Narrative on Simply Wall St, which compiles analysts' consensus price target and revenue and earnings forecasts, not one person's view.
"Nucor's multi year capital program of roughly US$15b to US$20b, with several mills and downstream assets already EBITDA positive and capital expenditure guiding to about US$2.5b in 2026..."
Discover why this Narrative puts Nucor at 20% undervalued.
Before forming a view on Nucor, it is worth knowing that Simply Wall St’s broader checks have also highlighted potential pressure points that investors often weigh alongside valuation and growth assumptions. Take a closer look at 1 warning sign before settling on a valuation.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com